Learn from experts in the field of CIDP.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode will overview important supportive care topics for cell-based therapies, primarily targeted for practitioners that have less exposure to these therapies but are now being introduced to their use. Specific topics will include tumor lysis syndrome and chemotherapy induced nausea and vomiting, anti-infective prophylaxis, cytokine release syndrome, and immune effector cell-associated neurotoxicity syndrome. CE for this episode expires 2 years after the date it was originally published.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Amy Pasternak and Dr. Jamie Park discuss the AJHP Descriptive Report "Establishing a CYP3A5 genotype–guided tacrolimus dosing protocol in adult kidney transplant recipients” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for an inspiring session where we explore how the pharmacist's role in medication safety is evolving. Speakers will share how ASHP's Practice Advancement Initiative 2030 is being integrated into practice, artificial intelligence use in advancing medication safety, and tips for student pharmacists on how to get involved in medication safety.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast discusses how pharmacists are expanding their roles in obesity management through collaborative practice agreements (CPAs) and innovative clinic workflows. Guests share their experiences launching and sustaining weight management services, highlighting operational considerations and billing strategies. Listeners will gain practical insights into establishing pharmacist-led obesity care models and supporting patients in achieving long-term success.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode will explore the concept of cognitive load, which describes the mental effort required to process information and directly impacts cognitive function. In the workforce, cognitive overload has been linked with occupational burnout. Addressing cognitive overload in the workplace is an available strategy to help manage occupational burnout. Listeners will learn about cognitive load theory, its linkage to occupational burnout, and strategies that may reduce cognitive load.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode includes authors from the recent AJHP theme issue on management of chronic kidney disease as well as pharmacists practicing in a variety of nephrology-related settings. The field of nephrology is evolving with new therapies and payment models, and pharmacists can positively impact patients throughout their continuum of kidney care. The panelists will discuss their impact on nephrology care and visions for the field. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, Luna Shi, chair of the New Practitioners Forum Executive Committee (NPF), sits down with the 2025 NPF Distinguished Service Awardee, Justin Moore, to discuss his leadership within the forum and ASHP and its impact on his professional journey. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast explores the science, policy, and clinical reasoning behind updated pediatric immunization schedules. This CE episode reviews current 2026 American Academy of Pediatrics and US Department of Health and Human Services pediatric immunization recommendations, examines the data supporting vaccine timing, and compares U.S. practices with international approaches. Through a patient-centered lens, the discussion highlights how shared decision-making can be applied in real-world pediatric care.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Gretchen Ray and Dr. Joe Anderson discuss the AJHP Clinical Research Report "Utilization rate and predictors of sodium-glucose cotransporter 2 inhibitor use in patients with heart failure: A continuing review” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.